Conference call Report on Operations 2015

Invitation to attend Vitrolife’s conference call regarding presentation of the
Report on Operations 2015. The presentation will be held in English.
Time: Friday, February 5, 2016 at 10.00 a.m. CET.

Registration can preferably be done 10-15 minutes before the conference start
time on:

Sweden dial in number: +46 (0)8 5052 0114

UK dial in number: +44 (0)207 1620 177

Conference name: Vitrolife, conference ID: 957429

Vitrolife participants:
Thomas Axelsson, CEO
Mikael Engblom, CFO
The press release for Vitrolife’s Report on Operations will be released at 8.30
CET on the same day.
Before the conference call, slides will be available at the company web page,
http://www.vitrolife.com (http://www.vitrolife.com/en/Corporate/)

A recorded version of the presentation will be available for seven days on
number

+46 (0)8 5052 0333 (Sweden) or 020 7031 4064 (UK), access code 957429.

Gothenburg, January 29, 2016
VITROLIFE AB (publ)
Queries should be addressed to:
Mikael Engblom, CFO, tel 46 31 721 80 14

Vitrolife is required to publish the information in this press release in
accordance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication
on January 29, 2016 at 08:30 a.m.

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.
________________________________________________________________________________
_ 
________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces
and markets medical devices for assisted reproduction. Work is also carried out
to enable the use and handling of stem cells for therapeutic purposes

Vitrolife has approximately 330 employees and the company's products are sold in
almost 110 markets. The company is headquartered in Gothenburg, Sweden, and
there are also offices in USA, Australia, France, Italy, United Kingdom, China,
Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX
Stockholm, Mid Cap.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity
number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail:
info@vitrolife.com. Website: www.vitrolife.com/